Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

ISSN 0965-0407

Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

Publisher: Cognizant Communication Corporation

Volume 14, Number 10, 2004

Purchase this issue

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Research Article

The Ability of New Sugar-Modified Derivatives of Antitumor Anthracycline, Daunorubicin, to Stimulate NAD(P)H Oxidation in Different Cellular Oxidoreductase Systems: NADH Dehydrogenase, NADPH Cytochrome P450 Reductase, and Xanthine Oxidase
pp. 469-474(6)
Authors: JolantaPawowska Pawowska; Waldemar Priebe; Mark J. I. Paine; C. Roland Wolf; Edward Borowski; Jolanta Tarasiuk

PAR₁-Type Thrombin Receptor Stimulates Migration and Matrix Adhesion of Human Colon Carcinoma Cells by a PKC-Dependent Mechanism
pp. 475-482(8)
Authors: Ilonka Heider; Beate Schulze; Elke Oswald; Peter Henklein; Johannes Scheele; Roland Kaufmann

Nicotinamide Relaxes Vascular Smooth Muscle by Inhibiting Myosin Light Chain Kinase-Dependent Signaling Pathways: Implications for Anticancer Efficacy
pp. 483-489(7)
Authors: Mark W. Ruddock; David G. Hirst

The Differential Proteome Profile of Stomach Cancer: Identification of the Biomarker Candidates
pp. 491-499(9)
Authors: Joung S.Jang Jang; Hee Y. Cho; Young J. Lee; Woo S. Ha; Hwal W. Kim

Proteolysis of Human Plasma Reveals the Presence of Complexes Formed by Endogenous Heparin and Peptides That Stimulate Angiogenesis
pp. 501-511(11)
Authors: Stefania Pacini; Marco Ruggiero; Fabiola Cecchi; Benedetta Peruzzi; Simonetta Vannucchi

In Vivo Molecular Pharmacology and Antitumor Activity of the Targeted Akt Inhibitor PX-316
pp. 513-527(15)
Authors: Emmanuelle J. Meuillet; Nathan Ihle; Amanda F. Baker; Jaime M. Gard; Chelsea Stamper; Ryan Williams; Amy Coon; Daruka Mahadevan; Benjamin L. George; Lynn Kirkpatrick; Garth Powis

The complete issue is available for purchase

$125.00

Purchasing this issue will give you access to all of the articles listed above for 2 days. You may also purchase articles individually by visiting the abstract page of the article. The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out.

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.